Chromosomal effect in vivo of exposure to lysergic acid diethylamide.
Chromosome studies of persons exposed to lysergic acid diethylamide, either self-administered or received during medical therapy, failed to demonstrate significant chromosomal damage.
D000328:Adult; D000987:Antisocial Personality Disorder; D002188:Cannabis; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects*; D046508:Culture Techniques; D005260:Female; D006213:Hallucinogens; D006801:Humans; D007962:Leukocytes / Q000166:cytology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011605:Psychoses, Substance-Induced; D012559:Schizophrenia; D014363:Tryptamines
D006213:Hallucinogens; D014363:Tryptamines; D008238:Lysergic Acid Diethylamide